RBC Capital Sticks to Its Buy Rating for Maravai Lifesciences Holdings (MRVI)

Retrieved on: 2024-04-09 08:12:12

Tags for this article:

Click the tags to see associated articles and topics

RBC Capital Sticks to Its Buy Rating for Maravai Lifesciences Holdings (MRVI). View article details on hiswai:

Excerpt

Read More on MRVI: Applied DNA Sciences enters manufacturing agreement with Alphazyme · Maravai LifeSciences Announces March 2024 Investor Conference ...

Article found on: markets.businessinsider.com

View Original Article